New Drug Approval: Fda's Consideration of Evidence From Certain Clinical Trials: Report to Congressional Requesters
Washington, DC: U.S. Government Accountability Office, 2010. 33 p. [Online.] Accessed: http://www.gao.gov/new.items/d10798.pdf [2011 July 14]
Showing items related by title, author, creator and subject.
NIH Extramural Clinical Research: Internal Controls Are Key to Safeguarding Phase III Trials Against Misconduct. Report to Congressional Requesters Unknown author (United States. General Accounting Office [GAO], 1996-07-11)